A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer.

Cancers (Basel) · 2021 · PMC8508147 · PMID 34638323

Europe PMC DOI

hedged sentences

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

approached significantp = 0.054so close (0.05 < p ≤ 0.1)

The logistic regression models for the 101-gene model with three prespecified alternative IM subtype thresholds only approached significant predictive power (OR, 3.03–3.14; p = 0.054), and results were very similar with all three thresholds ( Table 3 ).

also in 127 other papers

marginally significantno p-value reported

Similarly, xCell showed significantly higher levels of CD8+ T cells in patients with pCR than in those with non-pCR; this difference was marginally significant according to CIBERSORT.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.